View older revisions Content changed at 2025-03-21, 1404/01/01

Protocol summary

Study aim
Investigating the effect of "child's sleep guide" on sleep and severity of symptoms in 6-12 year old children with autism spectrum disorder.
Design
In this study, 30 participants will be randomly assigned to the intervention (15 people) and control (15 people) group. In order to randomize the allocation of samples to intervention and control groups, a random list of 30 people was produced in groups A and B, and by lottery (tossing a coin), the letter A or B will be considered for the samples of the intervention group and the control group.In two intervention and control groups, matching is done in terms of autism level.
Settings and conduct
The present study will be conducted on children with ASD aged 6 to 12 years, in schools or autism centers in Tehran or in the clinic of the rehabilitation faculty of Iran University of Medical Sciences without blinding.
Participants/Inclusion and exclusion criteria
having reading and writing literacy and complaining about sleep problems in children with ASD in parents; Having a diagnosis of ASD at Level 1 or 2 and the child scoring above 41 on the CSHQ; Having at least 5 years of clinical and research work experience related to children with ASD in specialists.
Intervention groups
Intervention group: Pretests and SSP-2 and CASES will be administered. Then, the content of the manual will be implemented by the child's main caregiver at home for 8 weeks. The Sleep Diary will be completed daily. Then the post-tests will be implemented. Follow-up assessments will be conducted 8 weeks after the end of the intervention. Control group: Pretests will be administered. The Sleep Diary will be completed daily. Children will receive common occupational therapy interventions. Then the post-tests will be implemented. Follow-up assessments will be conducted 8 weeks after the end of the intervention.
Main outcome variables
Sleep; Severity of symptoms

General information

Reason for update
Because we were unable to obtain accurate scores for one of the questionnaires, we changed the questionnaire and the age range of the participants changed according to the new questionnaire.
Acronym
IRCT registration information
IRCT registration number: IRCT20240105060616N1
Registration date: 2024-02-12, 1402/11/23
Registration timing: prospective

Last update: 2025-03-21, 1404/01/01
Update count: 1
Registration date
2024-02-12, 1402/11/23
Registrant information
Name
Simin Asadi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 5547 6212
Email address
asadi.si@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-05-21, 1403/03/01
Expected recruitment end date
2024-06-20, 1403/03/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Developing a «sleep guide for child with autism spectrum disorder for parents with emphasis on self-regulation strategies in occupational therapy » and investigating its efficacy on sleep and Severity of symptoms in children with autism spectrum disorder aged 6 to 12 years old: Randomized Clinical Trial
Public title
Developing a sleep guide for child with autism spectrum disorder and investigating its efficacy on sleep and Severity of symptoms in children with autism spectrum disorder
Purpose
Education/Guidance
Inclusion/Exclusion criteria
Inclusion criteria:
Inclusion criteria for parents: being able to read and write; Having complaint about sleep problems in child with ASD; Willingness and declaration of readiness to cooperate with the researcher to implement the intervention at home; Availability of at least one parent who can continuously participate in educational and research activities. Children's inclusion criteria: having an ASD diagnosis by a child psychiatrist; The severity of autism according to the GARS test be at level 1 or 2; Obtaining a score higher than 41 in CSHQ; The child is in the age range of 6 to 12 years. Having at least 5 years of clinical and research experience in working with children with ASD; Having expertise related to children with ASD such as pediatric psychiatrist, pediatric occupational therapist, pediatric psychologist.
Exclusion criteria:
Having a psychiatric disorder in the active phase, in the primary caregiver according to the SCID. Taking drugs that have the potential to induce sleep during the intervention and after 6 pm by the child (such as melatonin, benzodiazepines, antipsychotics such as haloperidol, olanzapine, risperidone, quetiapine, perphenazine, chlorpromazine, antidepressants such as imipramine, amitriptyline and clomipramine) The presence of severe medical problems in the child based on the medical record or as reported by the parents
Age
From 6 years old to 12 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Outcome assessor
Sample size
Target sample size: 30
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, we use the randomization list of the investigated samples in the intervention and control groups and by lottery (tossing a coin), the letter A or B will be considered for the samples of the intervention group and the control group. It is worth mentioning that in the two intervention and control groups, matching is done in terms of the level of autism.
Blinding (investigator's opinion)
Single blinded
Blinding description
The person who scores the outcome assessments and then enters them into the SPSS software is blind.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Iran University of Medical Sciences
Street address
Unit 2, No. 8, Hoveyda Alley, Shahid Mahloji Qomi St, Molvi St.
City
Tehran
Province
Tehran
Postal code
1196683311
Approval date
2023-12-27, 1402/10/06
Ethics committee reference number
IR.IUMS.REC.1402.805

Health conditions studied

1

Description of health condition studied
Autism Spectrum Disorder
ICD-10 code
F84.0
ICD-10 code description
Autistic disorder

Primary outcomes

1

Description
sleep
Timepoint
Before the intervention, After the intervention, At the follow-up time two months after the intervention.
Method of measurement
Children’s Sleep Habits Questionnaire (CSHQ)

2

Description
Severity of symptoms
Timepoint
Before the intervention, After the intervention, At the follow-up time two months after the intervention.
Method of measurement
Autism Treatment Evaluation Checklist (ATEC)

3

Description
Severity of symptoms
Timepoint
Before the intervention, After the intervention, At the follow-up time two months after the intervention.
Method of measurement
Sensory Processing Measure 2- child’s School form (SPM-2)

Secondary outcomes

1

Description
parent stress
Timepoint
Before the intervention, After the intervention, At the follow-up time two months after the intervention
Method of measurement
Parent Stress Index-Short form (PSI-SF)

2

Description
Executive Function
Timepoint
Before the intervention, After the intervention, At the follow-up time two months after the intervention
Method of measurement
Behaviour Rating Inventory of Executive Function-Parent version (BRIEF)

Intervention groups

1

Description
Intervention group: After designing and developing the manual with emphasis on self-regulation strategies for children with ASD aged 6 to 12 years based on the texts and compliance with OTPF and the "child-environment- sleep occupation" model, the research objectives are explained for the main caregivers of children with ASD. Then the demographic form will be completed. In the demographic form, the common occupational therapy treatment plan will be reported, and actions that directly or indirectly overlap or interfere with sleep interventions will be identified and controlled. Then the pre-tests (ATEC, SPM-2, CSHQ, PSI-SF, BRIEF) will be conducted in schools or autism centers or in the clinic of the rehabilitation faculty of Iran University of Medical Sciences, in the middle of the Season(so that the change of season does not affect the child's sleep). In the intervention group, SSP-2 will also be completed in order to determine the sensory needs of children with ASD in order to determine which part of the draft protocol to be taught to the family. Also, in the intervention group, a video or photo of the child's sleeping environment will be prepared by the family and matched with the "Child and Adolescent Sleeping Environment Scale" (CASES) so that environmental modifications in each child's sleeping environment can be considered if needed. Then, the content of the booklet will be taught to the main caregivers of the children in special sessions for implementation at home. In these sessions, according to the child's age, the child's sleeping environment, his sensory needs, and other conditions related to the child's home and family, some items in the booklet will be explained to the main caregiver. Then the intervention at home will be implemented by the main caregiver based on similar studies for 8 weeks. During this period, by using the Log Book, the family's loyalty to the implementation of the items taught in the meetings and the manual at home will be recorded by the main caregiver, and parents' feedback will be received and examined by weekly phone calls. At this stage, the MPOC-20 form will be completed monthly by the main caregiver of the child in order to check the views of the parents regarding the services provided by the researchers, and in this way, we will check the opinion of the main caregivers regarding the interventions. Also, in order to monitor children's sleep more accurately, the Sleep Diary will be completed daily by the main caregiver. Conducting secondary evaluations: CSHQ, ATEC, SPM-2, PSI-SF and BRIEF evaluations will be done again in autism centers or in the clinic of the rehabilitation faculty of Iran University of Medical Sciences in the middle of the year. Conducting follow-up evaluations: CSHQ, ATEC, SPM-2, PSI-SF and BRIEF evaluations will be done again 8 weeks after the end of the intervention.
Category
Rehabilitation

2

Description
Control group: After explaining the objectives of the research for the main caregivers of children with ASD, the demographic form will be completed. In the demographic form, the common occupational therapy treatment plan will be reported, and actions that directly or indirectly overlap or interfere with sleep interventions will be identified and controlled. Then the pre-tests (ATEC, SPM-2, CSHQ, PSI-SF, BRIEF) will be performed in the control group in schools or autism centers or in the clinic of the Rehabilitation Faculty of Iran University of Medical Sciences, in the middle of the Season (so that the change of season does not affect the child's sleep). Also, in order to monitor children's sleep more accurately, Sleep Diary will be completed daily by the main caregiver. Participants in the control group will receive common occupational therapy interventions provided in centers or schools, including cognitive or educational interventions, or social interventions, etc. Performing secondary evaluations: CSHQ, ATEC, SPM-2, PSI-SF and BRIEF evaluations will be done again in autism centers or in the clinic of the rehabilitation faculty of Iran University of Medical Sciences in the middle of the season. Conducting follow-up evaluations: CSHQ, ATEC, SPM-2, PSI-SF and BRIEF evaluations will be done again 8 weeks later.
Category
Rehabilitation

Recruitment centers

1

Recruitment center
Name of recruitment center
Schools or Autism Centers in Tehran or in the clinic of the rehabilitation faculty of Iran Universit
Full name of responsible person
Simin Asadi
Street address
Madadkaran Street; Shah Nazari Street; Mother Square; Mirdamad
City
Tehran
Province
Tehran
Postal code
۱۳۴۸۷ ۱۵۴۵۹
Phone
+98 21 2222 2059
Email
siminasadi.ot@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Reza Falak
Street address
5th floor of the central headquarters; Iran University of Medical Sciences; next to Milad Tower; Hemat Highway; Tehran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2504
Email
research-m@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Simin Asadi
Position
student
Latest degree
Master
Other areas of specialty/work
Occupational Therapy
Street address
No. 8; Hoveyda Alley; Shahid Mahloji Qomi St; Molvi St
City
Tehran
Province
Tehran
Postal code
1196683311
Phone
+98 21 5547 6212
Email
siminasadi.ot@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Samauneh Karamali Esmaeili
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Occupational Therapy
Street address
Faculty of Rehabilitation Sciences; Iran University of Medical Sciences; Shah Nazari St.; Madadkaran St.; Mader Square; Mirdamad; Tehran
City
Tehran
Province
Tehran
Postal code
1545913487
Phone
+98 21 2222 2059
Email
samauneh.esmaeili@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
SiminAsadi
Position
Student
Latest degree
Master
Other areas of specialty/work
Occupational Therapy
Street address
Unit 2; No. 8; Hoveyda Alley; Shahid Mahloji Qomi St.; Molvi St.
City
Tehran
Province
Tehran
Postal code
1196683311
Phone
+98 21 5547 6212
Email
siminasadi.ot@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
I have not consulted with the research team about this yet.
When the data will become available and for how long
I have not consulted with the research team about this yet.
To whom data/document is available
I have not consulted with the research team about this yet.
Under which criteria data/document could be used
I have not consulted with the research team about this yet.
From where data/document is obtainable
I have not consulted with the research team about this yet.
What processes are involved for a request to access data/document
I have not consulted with the research team about this yet.
Comments
Loading...